SE437329B - Sett att ur blodserum framstella vaccin mot virushepatit - Google Patents

Sett att ur blodserum framstella vaccin mot virushepatit

Info

Publication number
SE437329B
SE437329B SE7602871A SE7602871A SE437329B SE 437329 B SE437329 B SE 437329B SE 7602871 A SE7602871 A SE 7602871A SE 7602871 A SE7602871 A SE 7602871A SE 437329 B SE437329 B SE 437329B
Authority
SE
Sweden
Prior art keywords
blood serum
put out
virus hepatitis
against virus
vaccin
Prior art date
Application number
SE7602871A
Other languages
English (en)
Other versions
SE7602871L (sv
Inventor
A M Prince
J Vnek
A R Neurath
C Trepo
Original Assignee
Community Blood Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7508046A external-priority patent/FR2303562A1/fr
Application filed by Community Blood Council filed Critical Community Blood Council
Publication of SE7602871L publication Critical patent/SE7602871L/sv
Publication of SE437329B publication Critical patent/SE437329B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
SE7602871A 1975-03-14 1976-02-27 Sett att ur blodserum framstella vaccin mot virushepatit SE437329B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7508046A FR2303562A1 (fr) 1975-03-14 1975-03-14 Nouvelle preparation d'antigene utilisable comme vaccin
US05/631,961 US4118479A (en) 1975-03-14 1975-11-17 Vaccine for active immunization containing hepatitis B surface antigen and associated antigen

Publications (2)

Publication Number Publication Date
SE7602871L SE7602871L (sv) 1976-09-15
SE437329B true SE437329B (sv) 1985-02-25

Family

ID=26218778

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7602871A SE437329B (sv) 1975-03-14 1976-02-27 Sett att ur blodserum framstella vaccin mot virushepatit

Country Status (9)

Country Link
US (1) US4118478A (sv)
JP (1) JPS51133414A (sv)
AT (1) AT349136B (sv)
AU (1) AU505999B2 (sv)
CA (1) CA1066190A (sv)
DE (1) DE2610717C3 (sv)
MX (1) MX3473E (sv)
NL (1) NL7602621A (sv)
SE (1) SE437329B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen
ZA792485B (en) * 1978-06-07 1980-06-25 New York Blood Center Inc Vaccine for active immunization containing hepatitis b surface and/or e-antigens
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
JPH0625069B2 (ja) * 1981-01-29 1994-04-06 ブリティッシュ・テクノロジー・グループ・リミテッド Ｂ型肝炎ワクチン製造方法
DE3150935A1 (de) * 1981-12-23 1983-06-30 Uwe Dr.med. 3400 Göttingen Böttcher Verfahren zur herstellung eines hepatitis-b impfstoffes
US5324513A (en) * 1984-03-07 1994-06-28 Institut Pasteur Composition useful for the fabrication of vaccines
US4639371A (en) * 1984-10-02 1987-01-27 New York Blood Center, Inc. Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
US4024243A (en) * 1975-06-16 1977-05-17 Merck & Co., Inc. Process for isolating hepatitis B antigen

Also Published As

Publication number Publication date
AT349136B (de) 1979-03-26
DE2610717C3 (de) 1981-02-05
AU1196776A (en) 1977-09-15
ATA186276A (de) 1978-08-15
SE7602871L (sv) 1976-09-15
DE2610717B2 (de) 1980-05-14
DE2610717A1 (de) 1977-05-26
JPS51133414A (en) 1976-11-19
AU505999B2 (en) 1979-12-13
CA1066190A (en) 1979-11-13
MX3473E (es) 1980-12-10
US4118478A (en) 1978-10-03
NL7602621A (nl) 1976-09-16

Similar Documents

Publication Publication Date Title
SE440149B (sv) Sett att sammankoppla biologiska substanser med bensokinon
SE433222B (sv) Sett att framstella modifierad polysackarid
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
DK498376A (da) Adhesivpreparat
SE7412722L (sv) Formeringsvira och sett for dess framstellning
BR7604846A (pt) Fralda descartavel
MX143823A (es) Mejoras a jeringa desechable de dos compartimientos
DK149012C (da) Engangsble
SE7607240L (sv) Sett att framstella pyrrolettiksyraforeningar
SE7606280L (sv) Sett att framstella etrar
SE433492B (sv) Sett att framstella fenylettiksyraderivat
DK511576A (da) Fremgangsmade til at fremkalde storkning af blod
SE437329B (sv) Sett att ur blodserum framstella vaccin mot virushepatit
BE841811A (fr) Vaccin contre l'hepatite b
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
DK521476A (da) Engangssprojte
SE7604890L (sv) Sett att framstella perkarbonsyralosningar
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE423542B (sv) Sett att framstella 2,6-dimetyl-3metoxikarbonyl-4-(2'-nitrofenyl)-1,4-dihydropyridin-5-karbonsyraisobutylester
DK517176A (da) Fremstilling af ethylchlorthioformiat
BR7607428A (pt) Fralda descartavel
BR7608668A (pt) Fralda descartavel
SE7803840L (sv) Sett att framstella lekemedel mot diarreer
SE7607171L (sv) Sett att framstella indolokinoliziner
SE7600769L (sv) Sett att avferga avloppsvatten

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7602871-1

Effective date: 19880125

Format of ref document f/p: F